Luca Lovrecić

beroep: onderzoeker

Series

There is nothing here

Create a new serie

Werken

There is nothing here

Create a new work

Artikels 37

Date

Titel

Auteurs

2018-01-11

Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis

Nada Starčević Čizmarević, Maja Zivkovic, Miljenko Kapović, Juraj Sepčić, Luca Lovrecić, Stankovic A., Smiljana Ristić
2018-03-21

Diagnostic efficacy and new variants in isolated and complex autism spectrum disorder using molecular karyotyping.

Luca Lovrecić, Damjan Osredkar
2018-06-20

Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability

Luca Lovrecić, Federica Baldan
2017-03-23

Characterization of a de novo sSMC 17 detected in a girl with developmental delay and dysmorphic features

Luca Lovrecić
2017-10-01

Transcriptome Profiling Uncovers Potential Common Mechanisms in Fetal Trisomies 18 and 21

Luca Lovrecić
2017-11-28

Points to consider for laboratories reporting results from diagnostic genomic sequencing.

Amélie Piton, Danya F Vears, Angus Clarke, Luca Lovrecić, Koen Van Gassen, P Borry
2017-06-01

Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report

Smiljana Ristić, Nada Starčević Čizmarević, Luca Lovrecić, Juraj Sepčić, Miljenko Kapović
2017-11-18

Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape

Tiina Titma, P Kovác, Luca Lovrecić, Sirpa Soini, P Borry
2017-09-14

Comprehensive use of extended exome analysis improves diagnostic yield in rare disease: a retrospective survey in 1,059 cases

Luca Lovrecić
2016-03-31

Phenotype-driven gene target definition in clinical genome-wide sequencing data interpretation

Aleš Maver, Luca Lovrecić, Marija Volk, Alenka Hodzic
2016-11-15

Clinical utility of array comparative genomic hybridisation in prenatal setting

Luca Lovrecić, Borut Peterlin
2016-04-19

A New Case of an Extremely Rare 3p21.31 Interstitial Deletion

Luca Lovrecić
2016-09-08

11q terminal deletion and combined immunodeficiency (Jacobsen syndrome): Case report and literature review on immunodeficiency in Jacobsen syndrome

Luca Lovrecić
2015-03-13

No specific gene expression signature in human granulosa and cumulus cells for prediction of oocyte fertilisation and embryo implantation

Luca Lovrecić
2015-01-01

Direct-to-consumer genetic testing in Slovenia: availability, ethical dilemmas and legislation

Luca Lovrecić, Borut Peterlin
2015-08-27

Transcriptomic Analysis and Meta-Analysis of Human Granulosa and Cumulus Cells

Luca Lovrecić
2015-10-31

Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss

Luca Lovrecić, Borut Peterlin
2015-07-01

Nutriepigenomics: the role of nutrition in epigenetic control of human diseases

Luca Lovrecić
2015-01-12

Specific gene expression differences in cumulus cells as potential biomarkers of pregnancy

Luca Lovrecić
2015-07-02

MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?

Iva Gašparović, Luca Lovrecić, Juraj Sepčić, Miljenko Kapović, Smiljana Ristić
2014-03-25

An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge

Catherine A Brownstein, Timothy W Yu, Gerard Tromp, Peter White, Kim L McBride, Mikael Huss, Christian Gilissen, Alan H Beggs, Ingrid A Holm, Piotr Dworzynski, William G Fairbrother, Matthew S Lebo, Ignaty Leshchiner, Tune H Pers, Soumya Raychaudhuri, Heidi L. Rehm, Nathan O Stitziel, Richard J Smith, Val C Sheffield, Edwin M Stone, Benjamin Darbro, Todd E. Scheetz, Katherine Mathews, Colleen A Campbell, Anne E Kwitek, Thomas H Wassink, Douglas Van Daele, Kevin Booth, Luca Lovrecić, Andrey Alexeyenko, Jessica M Lindvall, Daniel Nilsson, Fulya Taylan, Kate Blair, Gustavo Glusman, Domingo González-Lamuño, María-Cruz Rodríguez, Ignacio Varela, Reece K Hart, Yong Kong, Jeremy Schwartzentruber, Bartha Knoppers, Sara Fitzgerald-Butt, Kym M Boycott, Borut Peterlin, Jacek Majewski, Peter Szolovits, Noam Shomron, A. Micheil Innes, Dennis E Bulman, Jillian S Parboosingh
2014-04-16

The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis

Maja Zivkovic, Nada Starčević Čizmarević, Luca Lovrecić, Stankovic A., Iva Gašparović, Polona Lavtar, Ljiljana Stojković, Juraj Sepčić, Miljenko Kapović, Smiljana Ristić, Borut Peterlin
2014-12-15

Therapeutic perspectives of epigenetically active nutrients

Luca Lovrecić, Ana Laura de la Garza, Fermin I Milagro
2013-09-16

Expression signature as a biomarker for prenatal diagnosis of trisomy 21

Luca Lovrecić, Peter Juvan, Borut Peterlin
2011-06-23

Angiotensin-converting enzyme gene polymorphism in patients with multiple sclerosis from Bosnia and Herzegovina

Luca Lovrecić, Juraj Sepčić, Miljenko Kapović, Smiljana Ristić
2009-11-01

Gene expression changes in blood as a putative biomarker for Huntington's disease

Luca Lovrecić, Andrej Kastrin
2009-10-01

Interstitial deletion 2p11.2-p12: further delineation

Luca Lovrecić
2008-10-22

Epidemiology of Huntington's disease in Slovenia

Luca Lovrecić
2007-06-01

The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes

Luca Lovrecić, Borut Peterlin
2007-10-01

Sodium phenylbutyrate in Huntington's disease: a dose-finding study

Luca Lovrecić
2007-01-12

Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients

Smiljana Ristić, Luca Lovrecić, Nada Starčević Čizmarević, Bojana Brajenović-Milić, Juraj Sepčić, Miljenko Kapović
2006-06-27

Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia

Luca Lovrecić, Bojana Brajenović-Milić

Human - wd:Q79327693

Welcome to Inventaire

de bibliotheek van je vrienden en communities

meer leren